BRAF mutations in prostate cancer are rare but do occur in around 2% of patients21,22, predominantly involving hotspot mutations in the activating kinase domain (p.K601E and p.G469A; Supplemental Fig. S7A,B)21,22,30. This evidence concerns the gene BRAF and Familial prostate cancer.